The GLP-1 price index for October 2026: what 24 programs charge
$149 a month, with auto-refill, at Strut Health is the lowest all-in cash price on the GLP Chart Price Index, checked October 12, 2026.
What every US GLP-1 telehealth program charges at maintenance dose. 34 cash-pay prices across the 24 programs we track (most publish a price for more than one drug), free to cite.
Buying rather than citing? Strut Health sells compounded semaglutide, a pharmacy-made version that is not FDA-approved and is not Wegovy, Ozempic, Zepbound or Mounjaro.
Every row below is a semaglutide product, and the compounded ones are not FDA-approved. The spread runs from a $25 copay to $998 a month. The form and the channel set that price.
Bought as
Monthly cost
Ozempic, cash at the pharmacy counter
Retail cash price with a GoodRx coupon. Varies by pharmacy.
$998/mo
reference
Wegovy pen, direct from NovoCare
Novo Nordisk's self-pay price through its NovoCare pharmacy, flat across maintenance doses. Cut from $499 in November 2025.
$349/mo
Wegovy pill, direct from NovoCare
The starter price covers the 1.5mg and 4mg doses only. Maintenance is the 9mg and 25mg doses, the ones most patients stay on.
$149/mo starter, $299/mo maintenance
Wegovy pill at NovoCare's standing price, through a telehealth program
The same $299/mo medication in every case. The spread is the membership fee stacked on top, and the bottom of it needs a 12-month membership plan.
$373/mo to $448/mo
Wegovy pill, on Novo's 12-month subscription
Novo drops the pill to $249/mo, but sells that price only through telehealth partners. You cannot get it from NovoCare. The membership fee is the rest.
$199 is the whole monthly cost, with no membership fee, and it does not change by dose. Entry-dose prices elsewhere start lower and do not hold.
$199/mo
With commercial insurance, after prior authorization
A copay, not a price. What you pay depends on your plan, not the program.
$25/mo
On Medicare, under the CMS GLP-1 Bridge
Flat rate for qualifying Part D members, July 1, 2026 through December 31, 2027. Covers Wegovy, Foundayo and the Zepbound KwikPen.
$50/mo
Rows marked “reference” are the retail counter price and Novo's subscription rate. The rest are checked every Monday against the seller's own page. Free to reuse under CC BY 4.0, see how to cite this.
For the full Wegovy cash path at each dose, see the Wegovy cost guide.
The advertised price is almost never what you pay at full dose. We measured that gap across every program.
24 programs: 22 scored, 2 manufacturer-direct. Cash prices, no insurance. A ~ means the program publishes no full-dose price, so we estimated it. Program names link to our review.
Download and cite this index
Published under Creative Commons CC BY 4.0. Reuse any number, chart row or download with attribution. The cheapest flat cash-pay GLP-1 program in October 2026 is $199/mo (GLP Chart, October 2026). Suggested citation:
GLP Chart Price Index, October 2026. glpchart.com/price-index. Checked Oct 12, 2026.
The index is one of 7 datasets we publish free to cite. The others, including prices by state and the compounded versus branded spread, are on the GLP-1 statistics page.
Membership rose from $49 to $79 between June 2025 and January 2026; the semaglutide add-on stayed $99, so the ongoing all-in went $148 to $178. The April and May 2026 pages show a struck $79 with a $39 first-month promo; the ongoing membership is still $79, so the all-in remains $178 and the $39 is not charted as a cut. The September, November and December 2025 snapshots showed only an as-low-as $99 medication headline, not an all-in, so they are dropped to keep one basis.
Noom Med$119/mo
advertised starting price for the medication-included GLP-1 program (intro figure, not full-dose maintenance)
These are starting-at intro prices, not the full-dose ongoing rate. Noom's published full-dose maintenance is $249 a month, which is what the site's Monday tracker records. The standard GLP-1 program intro fell from $149 to $119 by September 2025 and held. The May 2026 Microdose program at $99 is a different product tier and is not charted on this basis.
Eden$129/mo
advertised entry or first-month figure on a multi-month plan (not the ongoing monthly rate)
Every figure here is an entry or first-month number on a multi-month plan, so the line reads as the advertised lead price over time, not a like-for-like ongoing cost. The June 2025 $196 was on a 12-month plan. The advertised entry figure drifted down to $129 by early 2026.
Henry Meds (compounded injectable)$297/mo
advertised price for the compounded injectable semaglutide tier
Injectable semaglutide tier, shipped every 60 to 90 days, charted at the per-month figure shown on the page. Held at $297 across the captured snapshots. The January 2026 page shows a struck $149 next to the current $297; the $297 is charted as the current price. The oral semaglutide tier ($249) had only two usable snapshots and is not charted.
Hims (compounded injectable)$199/mo
advertised starting price for the compounded GLP-1 injectable program
Injectable starting price only. The starting figure dropped from $299 to $199 between July and August 2025 and held there. The oral kits ($69) and the compounded semaglutide pill added in February 2026 ($49 first month then $99) are different products and are not charted, since each had too few points to stand on its own basis.
Ivim Health (compounded semaglutide)$75/mo
advertised starting price for compounded semaglutide (medication only, program fee not included)
Medication-only starting price, which is a different basis from the site's verified all-in series for Ivim (that one adds the $74.99 program fee). The semaglutide starting price was cut from $99 to $75 in November 2025. The tirzepatide starting price and the four-month all-inclusive plan are separate figures and are not charted here.
Premium membership tier charted. Hone also lists a $25 basic tier; the premium tier is the full membership and is the figure shown. Membership only, medication is separate. Perfectly flat across six snapshots.
LifeMD$29/mo
monthly program fee (medication billed separately)
Program fee charted because LifeMD's branded drug prices (Wegovy and Zepbound) are separate line items that move on their own. The fee dropped from $75 to $29 a month by January 2026. The October 2025 snapshot listed drug prices but did not restate the program fee, so that month is a gap.
PlushCare$20/mo
monthly membership fee (visit and medication billed separately)
Membership fee charted at the listed $19.99, rounded to $20 for the axis. The $129 cash visit (or about $30 insured copay) and the medication itself are separate and run through insurance, so they are not part of this line. Flat across six snapshots.
Membership fee charted because Ro's medication prices are dose-dependent ranges (compounded semaglutide $349 to $499, later $199), not a single comparable figure. The membership rose from $145 to $149 in April 2026, a real move. The April page also shows a $39 first-month membership promo on top of the $149 ongoing rate; the ongoing $149 is charted, not the promo.
WeightWatchers Clinic$84/mo
ongoing monthly clinical program fee (medication billed separately)
Ongoing clinical program fee charted at $84 a month. The one-time consult fee moved on its own ($49, then a $25 promo) and is a separate figure, so it is not on this line. Medication is billed separately.
Found (branded Ozempic reference)$1,100/mo
listed branded Ozempic cash reference price (a reference price, not Found's program cost)
Found publishes branded reference prices, not a program all-in. The Ozempic reference price held near $1,100 across all ten snapshots. Wegovy and Zepbound were shown as from $650 and up. This line is a reference number for the brand-name list price, not what a Found patient pays.
Knownwell (branded Wegovy pen)$349/mo
listed cash price per box for the branded Wegovy pen (a reference price, not a program all-in)
Branded Wegovy pen regular cash price per box, charted as a single comparable figure. The page also lists a new-patient promo ($199 for the first two months) and separate Wegovy pill and Zepbound prices; those are different figures and are not charted on this line. Stable across four snapshots.
The 2025 compounding cliff
Through 2024 and into early 2025, compounded semaglutide ran about $99 to $199 a month by telehealth. The FDA declared the shortage over in February 2025, and the window for compounding closed on the April 22 and May 22, 2025 deadlines. The market split: branded Wegovy self-pay near $499 to $599 a month, or the compounded survivors that still run cash today.
One verified example. Mochi's archived June 2025 pricing showed $49 membership plus $99 medication, about $148 all-in. By September 2026 the same FAQ said the price varies by dose and printed only a floor, and the listing came off the chart.
CVS MinuteClinic headline maintenance price by week (USD per month)
Week
Price
May 25
no public price
Jun 1
no public price
Jun 8
no public price
Jun 15
no public price
Jun 22
no public price
Jun 29
no public price
Jul 6
no public price
Jul 13
no public price
Jul 20
no public price
Jul 27
no public price
Aug 3
no public price
Aug 10
no public price
Aug 17
$328/mo
Aug 24
$328/mo
Aug 31
$328/mo
Sep 7
$328/mo
Sep 14
$328/mo
Sep 21
$328/mo
Sep 28
$328/mo
Oct 5
$328/mo
Oct 12
$328/mo
How we built this
We read each program's own published price every Monday, cash-pay only, and never buy anything. Full method: methodology.
Frequently asked questions
What does a GLP-1 program cost per month in 2026?
Across the US telehealth programs in the index, published cash all-in prices run $149 a month (Strut Health, with auto-refill) to $448 a month (Hims & Hers, Ro Body and LifeMD). Shed holds a $199 flat rate at every dose. For branded medication, the Wegovy pill runs $299 a month cash at the maintenance dose through NovoCare (from $149 at the starter dose), and Zepbound vials run $399 a month cash at the 5mg maintenance dose through LillyDirect (from $299 at starter dose).
How are the prices verified?
Every price is checked every Monday, with a web-search fallback when a program hides pricing behind signup. Each row carries its verification date, and the source basis (all-in, membership plus medication, or insurance copay) is stated on the program page. We do not accept paid placements.
How often is the index updated?
Prices are checked every Monday. The downloadable index (CSV and PDF) is published monthly; the price-history series (CSV and JSON) records weekly observations per program, and a separate archive series carries snapshot-receipted prices for 13 programs back to June 2025.
Why you can trust GLP Chart. Same scoring framework applied to every program. No paid placements. We never remove unfavorable information at an advertiser's request. Pricing is pulled from each program's public-facing page every Monday.